ketamine treatment for depression nasal spray - Search News

FDA approves Johnson & Johnson’s nasal spray for depression

Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.

Hosted on MSN · 4h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

Fox Business · 1d

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

1d

J&J's ketamine-based nasal spray Spravato approved by US FDA to treat depression

The FDA approved Johnson & Johnson's Spravato, a ketamine-based nasal spray, to treat adults with major depressive disorder ...

Inquirer on MSN2d

Controlled drug Ketamine a lifeline for patients with severe depression in S’pore

Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results